|1.||Müller, Werner: 21 articles (11/2014 - 11/2004)|
|2.||Roers, Axel: 19 articles (07/2015 - 11/2004)|
|3.||Flavell, Richard A: 18 articles (08/2015 - 02/2006)|
|4.||Volk, Hans-Dieter: 18 articles (01/2015 - 04/2002)|
|5.||Wynn, Thomas A: 18 articles (02/2012 - 03/2002)|
|6.||Saha, Bhaskar: 16 articles (09/2015 - 05/2004)|
|7.||Sartor, R Balfour: 15 articles (10/2015 - 11/2004)|
|8.||Teixeira, Mauro M: 15 articles (11/2014 - 04/2002)|
|9.||Milligan, Erin D: 15 articles (01/2014 - 03/2004)|
|10.||Zhang, Jian: 14 articles (01/2016 - 01/2003)|
02/01/2012 - "Although Foxp3(+) regulatory CD4(+) T cells produce IL-10 during infection, highly activated IFN-γ(+) Th1 cells were shown to be the essential and sufficient source of IL-10 to guarantee protection against severe immune-mediated pathology. "
08/01/2007 - "This study evaluated associations between three single nucleotide polymorphisms in the IL10 promoter and clearance of low- or high-risk HPV infection in a cohort of 226 largely HIV-1-infected African-American adolescent females. "
09/15/2011 - "Ab4 infection resulted in a significant reduction of IL-10 responses in adult horses. "
12/23/2008 - "As a result, simultaneous blockade of IL-10 and PD-L1 was significantly more effective in restoring antiviral T-cell responses than blockade of either alone, and led to substantially enhanced control of an established persistent viral infection. "
06/01/1996 - "In vivo neutralization of IL-10 in BALB/c mice with an anti-IL-10 mAB during MoPn infection significantly increased the DTH response and enhanced clearance of MoPn. "
01/01/2014 - "The use of a genetically engineered food-grade bacterium, such as Lactococcus lactis, secreting the anti-inflammatory cytokine IL-10 has been proven by many pre-clinical studies to be a successful therapy to treat colon inflammation. "
04/01/1998 - "Treatment with IL-10 resulted in a marked improvement in intestinal inflammation. "
02/01/2008 - "Treatment with allergen-modified-DC suppressed airway inflammation and Th2 responses, and increased IL-10 and IFN-gamma production and Foxp3(+) Tregs significantly; and eliminated the responses of CD4(+) T cells to allergen. "
01/01/2002 - "Fact, that IL-10 is produced by Th1 and that inhibits cytokine production by Th2 lymphocytes has led to the concept that IL-10 might be beneficial in mitigating allergic inflammation. "
10/01/1999 - "In conclusion, reducing the inflammatory response to SCI by systemic administration of IL-10 resulted in a significant reduction in neuronal damage, suggesting that targeting injury-induced inflammation may be an effective treatment strategy for acute SCI."
02/01/2014 - "These data demonstrate that chronic supplementation with a natural mineral extract selectively ameliorates spontaneous mild-moderate colitis in Il10(-/-) mice on a C57BL/6 J, but does not attenuate more moderate-severe colitis in BALB/c strain animals."
01/01/2010 - "The aim of this study was to determine if administration of cis-UCA would be effective in attenuating colitis and the possible role of IL-10. "
08/01/2004 - "This study investigates the therapeutic efficacy of an adenovirus encoding IL-10 (AdvmuIL-10) in the treatment of experimental colitis. "
12/01/2002 - "This study investigates the therapeutic efficacy of an adenoviral vector encoding IL-10 (AdvmuIL-10) in experimental colitis. "
02/01/2009 - "We hypothesized that interleukin-10 delivery to the distal gastrointestinal tract using a unique delivery vehicle may serve as a novel therapeutic for the treatment of experimental colitis. "
12/01/2015 - "In this study, we provided evidence that MSCs derived from cervical tumors (CeCa-MSCs) cocultured with CeCa cells induced significant expression of TGF-β1 and secretion of IL-10 by CeCa cells compared to MSCs derived from the normal cervix (NCx-MSCs) and normal bone marrow (BM-MSCs; gold standard). "
01/01/2011 - "Importantly, we demonstrate that the role of IL-10 is critical, and not redundant with other immunosuppressive molecules, to in vivo tumor progression: blockade of the IL-10 signaling network results in alleviation of MDSC-mediated immunosuppression, altered T cell phenotype and activity, and improved survival. "
09/01/2015 - "Functional studies demonstrated that some factors, including IL10 and IL32-gamma, induced PD-L1 expression on monocytes but not tumor cells. "
06/01/2015 - "Previous studies investigated the associations of interleukin-10 (IL-10) polymorphisms with different types of cancer, indicating an influence on cancer risk. "
01/01/2015 - "We searched PubMed and EBSCO for studies in evaluating the association of IL-10 expression-in serum and clinical outcome in cancer patients. "
01/01/2008 - "The two fractions caused a significant reduction in production of tissue necrosis factor-alpha and an increase in interleukin 10 (IL-10)."
10/01/2003 - "Interleukin 10 gene transfection of donor lungs ameliorates posttransplant cell death by a switch from cellular necrosis to apoptosis."
10/01/2004 - "In this study, we investigated whether strain CR1 caused apoptosis or necrosis of macrophages after its inoculation into mice peritoneal cavity, and whether this correlated with the secretion of IL-10. "
09/15/2003 - "In this study, we show that IL-10 knockout mice infected with this parasite develop extensive areas of coagulative necrosis in the liver, and newborn larvae are required for lesion formation. "
03/01/2003 - "In in vitro cell cultures, there was reduced tumour necrosis factor-alpha and interleukin-10 production at week 26, with the latter persistent throughout the study period. "
|2.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|3.||Interleukin-6 (Interleukin 6)
|4.||Interleukin-4 (Interleukin 4)
|5.||Interleukin-12 (IL 12)
|6.||Messenger RNA (mRNA)
|7.||Interferon-gamma (Interferon, gamma)
|9.||Interleukin-10 (Interleukin 10)
|5.||Drug Therapy (Chemotherapy)